Psychiatric comorbidity in the evolution from migraine to medication overuse headache

被引:143
|
作者
Radat, F [1 ]
Creac'h, C
Swendsen, JD
Lafittau, M
Irachabal, S
Dousset, V
Henry, P
机构
[1] CHU Pellegrin, UTDC, Chron Pain Treatment Unit, F-33076 Bordeaux, France
[2] Univ Bordeaux 2, Dept Psychopathol, F-33076 Bordeaux, France
[3] Univ Bordeaux 2, Dept Hlth Psychol, F-33076 Bordeaux, France
关键词
comorbidity; medication overuse headache; migraine; psychiatric disorder;
D O I
10.1111/j.1468-2982.2005.00910.x
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
We set out to study the role of psychiatric comorbidity in the evolution of migraine to medication overuse headache (MOH) by a comparative study of 41 migraineurs (MIG) and 41 patients suffering from MOH deriving from migraine. There was an excess risk of suffering from mood disorders [odds ratio (OR) = 4.5, 95% confidence interval (CI) 1.5, 13.5], anxiety (OR = 5, 95% Cl 1.2, 10.7) and disorders associated with the use of psychoactive substances other than analgesics (OR = 7.6, 95 % Cl 2.2, 26.0) in MOH compared with MIG. Retrospective study of the order of occurrence of disorders showed that in the MOH group, psychiatric disorders occurred significantly more often before the transformation from migraine into MOH than after. There was no crossed-family transmission between MOH and psychiatric disorders, except for substance-related disorders. MOH patients have a greater risk of suffering from anxiety and depression, and these disorders may be a risk factor for the evolution of migraine into MOH. Moreover, MOH patients have a greater risk of suffering from substance-related disorders than MIG sufferers. This could be due to the fact that MOH is part of the spectrum of addictive disorders.
引用
收藏
页码:519 / 522
页数:4
相关论文
共 50 条
  • [31] Analysis of Leukocytes in Medication-Overuse Headache, Chronic Migraine, and Episodic Migraine
    Forcelini, Cassiano M.
    Dantas, C. M.
    Luz, Clarice
    Santin, Ricardo
    Stein, Airton T.
    Barros, Helena M. T.
    Barea, Liselotte M.
    HEADACHE, 2011, 51 (08): : 1228 - 1238
  • [32] Chronic migraine plus medication overuse headache: two entities or not?
    Negro, Andrea
    Martelletti, Paolo
    JOURNAL OF HEADACHE AND PAIN, 2011, 12 (06): : 593 - 601
  • [33] Internal stigmatization in patients with chronic migraine and medication overuse headache
    Firdevs Ezgi Uçan Tokuç
    Eylem Özaydın Göksu
    Şennur Delibaş Katı
    BMC Neurology, 24
  • [34] Chronic migraine and medication-overuse headache through the ages
    Boes, CJ
    Capobianco, DJ
    CEPHALALGIA, 2005, 25 (05) : 378 - 390
  • [35] Predictive index for the onset of medication overuse headache in migraine patients
    Onaya, T.
    Ishii, M.
    Katoh, H.
    Shimizu, S.
    Kasai, H.
    Kawamura, M.
    Kiuchi, Y.
    NEUROLOGICAL SCIENCES, 2013, 34 (01) : 85 - 92
  • [36] Risk of Medication Overuse Headache Across Classes of Treatment for Migraine
    Thorlund, K.
    Kanters, S.
    Druyts, E.
    Eapen, S.
    Ebrahim, S.
    Bhambri, R.
    Ramos, E.
    Mills, E.
    HEADACHE, 2014, 54 : 51 - 51
  • [37] Chronic migraine plus medication overuse headache: two entities or not?
    Andrea Negro
    Paolo Martelletti
    The Journal of Headache and Pain, 2011, 12 : 593 - 601
  • [38] Insights from medication overuse headache
    Lundqvist, A. C.
    EUROPEAN JOURNAL OF NEUROLOGY, 2019, 26 : 4 - 4
  • [39] Psychological aspects, comorbidity and drugs usage in medication overuse headache patients
    Iannacchero, R.
    Migliazza, F.
    Squillace, A.
    Vescio, G.
    Costa, A.
    JOURNAL OF HEADACHE AND PAIN, 2014, 15
  • [40] Medication overuse headache
    Ashina, Sait
    Terwindt, Gisela M. M.
    Steiner, Timothy J. J.
    Lee, Mi Ji
    Porreca, Frank
    Tassorelli, Cristina
    Schwedt, Todd J. J.
    Jensen, Rigmor H. H.
    Diener, Hans-Christoph
    Lipton, Richard B. B.
    NATURE REVIEWS DISEASE PRIMERS, 2023, 9 (01)